Latest GSK Stories
RESEARCH TRIANGLE PARK, N.C., May 19, 2015 /PRNewswire/ -- New data from a school asthma management program, "Building Bridges for Asthma Care," presented today at the American Thoracic Society 2015
Unique public-private collaboration will create HIV Cure center and a new company to bring together academic and pharmaceutical research scientists CHAPEL HILL, N.C., May 10, 2015
- Kids use chemistry to turn pennies golden in STEM experiments PHILADELPHIA, March 23, 2015 /PRNewswire/ -- GSK (LSE/NYSE: GSK), one of the world's leading research-based pharmaceutical and
BARCELONA, March 17, 2015 /PRNewswire/ -- Veeva Systems Inc.
LONDON, March 3, 2015 /PRNewswire/ -- Report Details Vaccines and their technology - your guide to developments, opportunities and revenues See what the future
LONDON, December 3, 2014 /PRNewswire/ -- Opportunities for Leading Companies Report Details Asthma and COPD therapies - new study showing you
Three years after CDC recommendations, vaccination rates still low; AADE encourages members to focus more on helping to prevent hepatitis B PHILADELPHIA and CHICAGO, Nov.
CARLSBAD, Calif., Nov. 3, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
LONDON, July 23, 2014 /PRNewswire/ -- Global healthcare company GSK reports Q2 results reflecting a business that is facing currency headwinds, increased price competition
Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK SUNNYVALE, Calif., June 19, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced a new collaboration with
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.